Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
Karmali R, Abramson JS, Stephens DM, Barnes J, Winter JN, Ma S, Gao J, Kaplan J, Petrich AM, Hochberg E, Takvorian T, Mi X, Nelson V, Gordon LI, Pro B.
Karmali R, et al. Among authors: petrich am.
Blood Adv. 2023 Dec 12;7(23):7361-7368. doi: 10.1182/bloodadvances.2023011271.
Blood Adv. 2023.
PMID: 37756532
Free PMC article.